Rheumatoid Arthritis Drugs Market Size, Share, And Growth Report 2032

Rheumatoid Arthritis Drugs Market: Size

The global Rheumatoid Arthritis Drugs Market size was worth around USD 18.35 billion in 2023 and is predicted to grow to around USD 27.74 billion by 2032 with a compound annual growth rate (CAGR) of roughly 4.7% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the Rheumatoid Arthritis Drugs Market on a global and regional level.

Request Free Sample

Rheumatoid Arthritis Drugs Market: Overview

Rheumatoid arthritis (RA) is an autoimmune disorder that leads to pain and inflammation of the joints. It usually affects the joints of wrists, elbows, hands, ankles, and knees. Some type of RA also affects the respiratory and cardiac systems, which is known as a systemic disease. These usually affect the geriatric population base, and the prevalence is high among the female population as compared to males. RA is also known as a musculoskeletal disease, as it causes deformity and severe pain in some areas of the musculoskeletal system. In some cases, redness, warmth, and swelling in the affected areas are also exhibited.

The presence of biologics and biosimilars, the rising prevalence of the disease, and established regulatory guidelines are likely to boost the rheumatoid arthritis drugs market growth globally. As per the Arthritis Foundation, around 64% population aged 65 or above is likely to suffer from arthritis in the U.S. The incidence of RA widely differs in different regions, i.e., higher rates are observed among the American populations while lower rates in the Asian countries. As per the CDC, the prevalence of RA in the U.S. is approximately 0.6% of the total population. Generally, RA affects twice the number of women as compared to men. According to the WHO, the RA prevalence varies between 0.3% and 1% and is more prominent in developed countries. The rising disease remittance therapies awareness and increasing healthcare expenditure in developed countries are likely to further promote rheumatoid arthritis drugs market growth globally in the future.

Request Free Sample

Rheumatoid Arthritis Drugs Market: Segmentation

The study provides a decisive view of the rheumatoid arthritis drugs market based on drug type, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

Based on drug type, the market for rheumatoid arthritis drugs is classified into NSAID’s, analgesics, DMARD’s, glucocorticoids, biologics, and others. The biologics segment further includes TNF-α antagonists, T-cell inhibitors, CD20 antigen, JAK inhibitors, and anti-IL6 biologics.

On the basis of the distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, drug stores, and online sales.

Rheumatoid Arthritis Drugs Market: Report Scope

Rheumatoid Arthritis Drugs Market: Regional Analysis

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

By region, North America is likely to dominate the rheumatoid arthritis drugs market globally in the future. The U.S. is at the forefront in terms of growth in this region. The rheumatoid arthritis drugs market in the Asia Pacific region is estimated to witness a high growth rate in the years ahead, owing to the rising healthcare expenditure and low manufacturing costs in India and China have resulted in the rise of production facilities which is attracting more pharmaceutical and biotechnological key players to this region.

Rheumatoid Arthritis Drugs Market: Competitive Players

Some leading players of the global rheumatoid arthritis drugs market include:

• Boehringer Ingelheim GmbH
• Regeneron Pharmaceuticals Inc.
• Johnson & Johnson
• Amgen Inc.
• UCB S.A.
• Pfizer Inc.
• Bristol-Myers Squibb
• AbbVie
• F. Hoffmann-La Roche AG
• Novartis International AG.

The Global Rheumatoid Arthritis Drugs Market is segmented as follows:

Global Rheumatoid Arthritis Drugs Market: Drug Type Analysis

• NSAID’s
• Analgesics
• DMARD’s
• Glucocorticoids
• Biologics
  • TNF-α Antagonists
  • T-Cell Inhibitors
  • CD20 Antigen
  • JAK Inhibitors
  • Anti-IL6 Biologics
• Others

Global Rheumatoid Arthritis Drugs Market: Distribution Channel Analysis

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Sales

Global Rheumatoid Arthritis Drugs Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa